ambroxol
Also known as Bromhexine-metabolite vIII, 4-(((2-Amino-3,5-dibromophenyl)methyl)amino)cyclohexanol, SID29215331, SID50085991, Tabcin (TN), trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol, trans-4-((2-Amino-3,5-dibromobenzyl)amine)cyclohexanol, 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup.
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 464186402
- Drug.IUPAC_name
- trans-4-(2-Amino-3,5-dibromobenzylamino)-cyclohexanol
- Drug.image
- Ambroxol structural formulae.png
- Drug.image_class
- skin-invert-image
- Drug.image2
- Ambroxol ball-and-stick.png
- Drug.image_class2
- bg-transparent
- Drug.ATC_prefix
- R05
- Drug.ATC_suffix
- CB06
- Drug.legal_status
- otc
- Drug.routes_of_administration
- oral, inhaled, intramuscular, intravenous
- Drug.metabolism
- CYP3A4
Article
6 sectionsContents
- Medical uses
- Side effects
- Mechanism of action
- Brand names
- See also
- References
Ambroxol is a drug that breaks up phlegm, used in the treatment of respiratory diseases associated with viscid or excessive mucus. Ambroxol is often administered as an active ingredient in cough syrup.
It was patented in 1966 and came into medical use in 1979.